David Charles Link serves as Executive at SAB Biotherapeutics, Inc., where they oversee executive responsibilities. Since joining the company, David Charles Link has executed 5 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Dec 7, 2022 involved receiving (via award) 41,493 shares valued at $50.2K.
David Charles Link currently holds 57,313 shares of SAB Biotherapeutics, Inc. (SABS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David Charles Link has been a net neutral trader of SABS stock. They have purchased $0 and sold $0 worth of shares.
David Charles Link's most recent insider trade was on Dec 7, 2022, when they sold 41,493 shares at $1.21 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Dec 6, 2021 | QSAM | $0 | Other | 850 | $N/A | Discretionary |
| Oct 22, 2021 | SABS | $0 | Award | 12,097 | $N/A | Discretionary |
| Oct 22, 2021 | SABS | $0 | Award | 15,820 | $N/A | Discretionary |